Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A UCLA study has outlined a new framework that researchers say would improve the predictive power of genetics to determine ...

A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would ...

Women who have had a stroke may be less likely than men to take medications to prevent a second stroke, with Mexican American women reporting the highest rates of nonadherence, according to new ...

An analysis of more than 1,300 stroke survivors found that women were less likely than their male counterparts to take ...

Esperion files new drug submissions in Canada for Nexletol and Nexlizet as a treatment for reducing bad cholesterol and ...

Esperion (ESPR) has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications ...

Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...

including Non-Alcoholic Steatohepatitis (NASH), fibrosis, and eventually cirrhosis. NAFLD is considered the hepatic ...

Dutch clinical-stage biotech NewAmsterdam Pharma, which is focused on non-statin medicines for patients at risk of ...

In patients who have coronary artery disease, peripheral artery disease or carotid artery disease, there is no question about the benefit of cholesterol-lowering medications such as statins.

QUESTION: Watch out for serious drug interactions with Preparation H! A few years ago, I was taking a beta blocker drug ...